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Mycobacterium kansasii is an emerging non-tuberculous mycobacterial (NTM) pathogen
capable of causing severe lung disease. Of the seven currently recognized M. kansasii
genotypes (I-VII), genotypes I and II are most prevalent and have been associated
with human disease, whereas the other five (III-VII) genotypes are predominantly
of environmental origin and are believed to be non-pathogenic. Subtyping of
M. kansasii serves as a valuable tool to guide clinicians in pursuing diagnosis and
to initiate the proper timely treatment. Most of the previous rapid diagnostic tests for
mycobacteria employing the matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) technology focused on species-level identification.
The purpose of this study was to establish MALDI-TOF MS reference spectra database
for discrimination of M. kansasii at the genotype level. A panel of 32 strains,
representatives ofM. kansasii genotypes I-VI were selected, whole cell proteins extracted
and measured with MALDI-TOF MS. A unique main spectra (MSP) library was created
using MALDI Biotyper Compass Explorer software. The spectra reproducibility was
assessed by computing composite correlation index and MSPs cross-matching. One
hundred clinical M. kansasii isolates used for testing of the database resulted in 90%
identification at genus-level, 7% identification at species-level and 2% identification was
below the threshold of log score value 1.7, of which all were correct at genotype level. One
strain could not be identified. On the other hand, 37% of strains were identified at species
level, 40% at genus level and 23% was not identified with the manufacturer’s database.
The MALDI-TOF MS was proven a rapid and robust tool to detect and differentiate
between M. kansasii genotypes. It is concluded that MALDI-TOF MS has a potential
to be incorporated into the routine diagnostic workflow ofM. kansasii and possibly other
NTM species.
Keywords: Biotyper, matrix-assisted laser desorption ionization—time of flight mass spectrometry, microflex,
Mycobacterium kansasii, genotypes
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INTRODUCTION
Mycobacterium kansasii is one of the leading causative agents
of pulmonary and extrapulmonary infections due to non-
tuberculous mycobacteria (NTM). It is also among the top six
most frequently isolated NTM species across the world. The
isolation rate of this pathogen is exceptionally high in Slovakia,
Poland, and the UK, that is 36, 35, and 11% respectively,
compared to a mean isolation rate of 5% in Europe and 4%
globally (Hoefsloot et al., 2013).
The major clinical manifestations attributable to M. kansasii
include fibro-cavitary or nodular-bronchiectatic lung disease,
lymphadenitis, skin, and soft-tissue infections, and disseminated
disease (van Ingen and Kuijper, 2014).
Pulmonary diseases caused by M. kansasii tend to cluster
in specific geographical areas, such as central Europe or
metropolitan centers of London, Brasilia, and Johannesburg
(Hoefsloot et al., 2013). In most of the countries there is no
obligation of registration of such cases, thus the true incidence of
M. kansasii disease is largely unknown. The estimated incidence
of infections due to this pathogen, reported in the general
population, fall within the range of 0.3–1.5 cases per 100,000
(Santin et al., 2004; Moore et al., 2010; Namkoong et al., 2016).
As with other NTM, M. kansasii infections are believed to be
acquired from environmental exposures rather than by person-
to-person transmission. Rarely hasM. kansasii been isolated from
soil, natural water systems or animals. Instead, the pathogen has
commonly been recovered from municipal tap water, which is
considered to be its major environmental reservoir (Thomson
et al., 2014).
The existence of five (I–V) distinct M. kansasii types was
initially evidenced by unique DNA profiles they produced
upon hybridization with the major polymorphic tandem
repeat (MPTR) probe, pulsed-field gel electrophoresis (PFGE),
amplified fragment length polymorphism (AFLP) analysis, and
PCR restriction enzyme analysis (PCR-REA) of the hsp65 gene
(Alcaide et al., 1997; Picardeau et al., 1997). In somewhat later
studies two novel types (VI and VII) have been described,
with similar methods (Taillard et al., 2003). This intra-species
polymorphism has important clinical and epidemiological
implications. Genotypes I and II have been involved in human
disease, with the former being the most prevalent, whereas
the remaining genotypes have usually been non-pathogenic.
Therefore, recovery of M. kansasii type I and II isolates
from clinical specimens should raise a clinical suspicion of
M. kansasii disease. Furthermore, M. kansasii type I has been
found more likely to be recovered from immunocompetent
individuals, whereas type II has been linked to patients with
some form of immunosuppression (Taillard et al., 2003).
Furthermore, despite a paucity of studies, there seems to be some
genotype-specific differences in drug susceptibility profiles. For
instance, clarithromycin resistance appears to be associated with
M. kansasii type I (Li et al., 2016), while M. kansasii type V,
contrary to all other types, shows susceptibility to ethambutol
Abbreviations: MALDI-TOF MS, Matrix-assisted laser desorption ionization-
time-of-flight mass spectrometry; MSP, main spectra libraries.
(Bakuła et al., 2018). Currently, identification of M. kansasii
genotypes is performed by PCR-sequencing or PCR-REA of the
hsp65, rpoB, and tuf genes (Telenti et al., 1993; Kim et al.,
2001; Bakuła et al., 2016). These methods, though accurate
and reproducible, require post-PCR manipulations, which are
time-consuming and laborious. A fast, reliable and automated
screening method for M. kansasii genotype determination is
needed.
In the past two decades, MALDI-TOF MS-based species
identification has been integrated into the routine diagnostic
workflow in microbiology laboratories due to its rapidness,
reliability, cost-effectiveness, and high throughput. A prerequisite
for MALDI-TOF MS profiling is a robustly established reference
spectra database. The growing accessibility of MALDI-TOF
MS instruments along with spectra pattern matching software
databases made that the interest in this technology and its
applications across research and diagnosis has exponentially
increased (Wattal et al., 2017).
In this study, a commercially available software package,
MALDI Biotyper (Bruker Daltonics) was used for creation of
genotype-specific reference database ofM. kansasii.
MATERIALS AND METHODS
Mycobacteria Strains and Isolates
A total of 32 strains, representing I-VI genotypes of
Mycobacterium kansasii were used to establish a MALDI-
TOF MS spectra reference database (Table 1). In addition, 100
clinical M. kansasii isolates were used for evaluation of the
database. The species identity of these isolates was confirmed
with the high-pressure liquid chromatography (HPLC). Genomic
DNA was extracted with the AMPLICOR Respiratory Specimen
Preparation Kit (Roche, Basel, Switzerland). Genotyping was
performed upon PCR-REA of hsp65 and tuf genes, as previously
described (Telenti et al., 1993; Bakuła et al., 2016).
Culture and Protein Extraction
A single bacterial colony was picked from Löwenstein-Jensen
(L-J) slant and used for inoculation of 10mL of Middlebrook
7H9 medium supplemented with glycerol and OADC (10%)
(Becton-Dickinson, Franklin Lakes, USA). The bacteria were
cultured at 37◦C with shaking for 7 days. Each strain/isolate
was cultured independently for three independent replicates.
The cells were harvested by brief centrifugation (4,500 rpm,
2min) and killed by suspending in 300µL of deionized water
and 900µL of absolute ethanol. After centrifugation (12,000
rpm, 2min) at room temperature (RT), excessive ethanol was
discarded and the samples were air-dried completely. The cell
pellet was dissolved in 50µL of 70% formic acid and 50µL
acetonitril. The samples were then subjected to sonication on
ice for 1min (cycle, 1.0; amplitude, 100%) using a sonicator
(UP100H, Hielscher Ultrasound Technology, Teltow, Germany).
The suspension was centrifuged at 12,000 rpm for 2min at RT,
and 1.0µL of the clear supernatant was spotted in triplicate onto
the MALDI target (MSP 96 target polished steel (MicroScout
Target) plate, Bruker Daltonik, Bremen, Germany). Following
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TABLE 1 | M. kansasii strains and their genotypes utilized for generation of reference spectra.
S. No Strain designation Genotype Source NTM disease Country
1 M. kansasii ATCC12478T I No data Yes USA
2 M. kansasii ATCC25221T Sputum Yes Germany
3 M. kansasii NLA001000449 Sputum Yes Netherlands
4 M. kansasii NLA001000521 Bronchoalveolar lavage fluid Yes Netherlands
5 M. kansasii 1502/11 Bronchoalveolar lavage fluid Yes Poland
6 M. kansasii 803/13 Bronchial washing Yes Poland
7 M. kansasii 5482/08 Bronchial washing Yes Poland
8 M. kansasii 305/01 Sputum No Poland
9 M. kansasii 1010001495E Water – Czech Republic
10 M. kansasii 10130/12 No data Yes Germany
11 M. kansasii 4911/16 Sputum Yes Germany
12 M. kansasii 8034/16 Bronchoalveolar lavage fluid Yes Germany
13 M. kansasii 8050/16 No data Yes Germany
14 M. kansasii 8091/16 No data Yes Germany
15 M. kansasii 8112/16 Bronchoalveolar lavage fluid Yes Germany
16 M. kansasii 8617/16 Sputum Yes Germany
17 M. kansasii B11063838 II Bronchoalveolar lavage fluid No Netherlands
18 M. kansasii B11073207 Sputum No Netherlands
19 M. kansasii NLA001001128 Bronchoalveolar lavage fluid No Netherlands
20 M. kansasii 2193/11 Bronchial washing No Poland
21 M. kansasii 1010001469E Water – Italy
22 M. kansasii 8190/16 Tracheal secretion Yes Germany
23 M. kansasii 8709/16 Bronchial secretion Yes Germany
24 M. kansasii 1010001468E III Soil – Belgium
25 M. kansasii 8197/16 No data Yes Germany
26 M. kansasii 101 No data Yes Germany
27 M. kansasii 1010001458E IV Tap water – Germany
28 M. kansasii 1010001454E V Tap water – Germany
29 M. kansasii 1010001493E Water – Netherlands
30 M. kansasii 6097/16 Bronchial secretion Yes Germany
31 M. kansasii NLA001001166 VI Sputum No Netherlands
32 M. kansasii NTM G7 Lu1 Gundi, lung tissue Yes Germany
TType strain, EEnvironmental isolate.
air drying each sample was overlaid with 1.0µL of saturated α-
cyano-4-hydroxycinnamic acid matrix solution and allowed to
dry completely prior to MALDI-TOF measurement.
MALDI Measurements
Bruker MALDI Microflex LT (Bruker Daltonics, Bremen,
Germany) with a linear positive mode of spectra acquisition, at
a laser frequency of 20Hz was used for the measurements. A
broadm/z range (2,000–20,000 kDa) of spectra was automatically
acquired using the AutoXecute acquisition control software
(Flex control 3.0, Bruker Daltonics, Leipzig, Germany) with the
following instrument settings: ion source 1 at 20 kV, ion source 2
at 16.7 kV, lens at 6 kV, extraction delay time of 150 ns, 240 laser
shots/spot in 40 shot steps (randomwalk movement), initial laser
power of 45%, maximal laser power of 55%, laser attenuation
Offset of 46% and at the range 30%). The bacterial test standard
(BTS) mixture covering the mass range between 2,000 and 20,000
Da (BTS, Bruker Daltonics, Bremen, Germany), was used for
external calibration.
MSP Library Construction
The spectra quality and reproducibility were assessed by
using Flex analysis 3.0 software (Bruker Daltonics, Bremen,
Germany). For every strain/isolate, 27 spectra representing three
independent culturing and three technical replicates and 3
measurements per replicate were collected. The raw spectra
were loaded in the MALDI Biotyper Compass Explorer 4.1
and matched against the commercial BDAL database—updated
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version 6.0.0.0 with 6,903 Main Spectra (MSP) entries (including
75 for mycobacteria with seven genotype undefined M. kansasii
entries)—plus the in-house entries of Staphylococcus intermedius
group of microorganisms (60 entries) (Murugaiyan et al., 2014)
and microalgae Prototheca species (23 entries) (Murugaiyan
et al., 2012). The spectra preprocessing parameters included
mass adjustment (lower bound- 3,000, upper bound- 15,000;
resolution-1 and spectra compressing factor- 10), smoothing
(Savitzky-Golay algorithm with a frame size of 25 Da),
baseline correction (multipolygon with search window 5 Da and
number of runs 2), normalization (maximum norm), and peak
detection (spectra differentiation with maximum peaks of 100,
signal-to-noise ratio 3 and threshold of 0.001). Main spectrum
profiles (MSPs) were created for each strain using the following
parameters: maximummass error for each single spectrum 2,000,
mass error for the MSP 100, peak frequency minimum 70%, and
maximum peak number 70. The details of the newly created
reference spectra will be listed at the MALDI-UP, an online
platform for the MALDI-TOF mass spectra (Rau et al., 2016)
to facilitate exchange of the reference spectra as btmsp files with
users from other laboratories.
Statistical Evaluations
To evaluate the spectral variation (similarity) between the spectra
sets acquired from strains of all genotypes, the Composite
Correlation Index (CCI) was calculated with MALDI Biotyper
Compass Explorer 4.1. All measured spectra were loaded and
CCI was computed using the following settings, mass lower
bound 3,000, mass upper bound 12,000, resolution 4, and CCI
parameter interval of 8. CCI value nearing 1.0 indicates the
complete congruence and 0.0 – complete deviation within the
spectra sets.
Following the creation of spectral reference database, the
genotype discrimination limits were assessed by crosswise
comparison bymatching the newly createdM. kansasii genotype-
specific MSPs with an augmented BDAL commercial database
described earlier. The resulted log score values of the first
hits were imported into MS excel and conditional formatting,
in accordance to the manufacturer’s recommended cutoff log
score values, was applied to generate a heat-map. The score-
oriented MSP dendrogram (distance level: correlation and
linkage: average) was also calculated using the MALDI Biotyper
Compass Explorer 4.1 software to explore the closeness of the
genotypes in terms of arbitrary distance level.
Blind Coded Sample Testing
For validation purposes, 100 clinical M. kansasii isolates
and single reference strains of M. conspicuum, M. marinum,
M. szulgai, and M. gastri were subjected to MALDI-TOF MS
identification, by comparing with the database before and after
addition of genotype-specific MSPs (Supplementary Table 1).
The isolates used for validation, had previously been identified,
as specified above and blind coded. The log score values
for species discrimination, recommended by the manufacturer,
were applied i.e., 0–1.699 indicating “no reliable identification”,
1.7–1.999 indicating a “probable genus identification”, 2.0–
2.299 indicating a “secure genus identification and probable
species identification” (PSI), and 2.300–3.000 indicating a “highly
probable species identification.”
RESULTS
A total of 32 strains representing genotypes I-VI of M. kansasii
were used to establish M. kansasii genotype-specific reference
spectra library. The choice of the strains was based on the
availability of strains representing a given genotype and strains of
genotype VII were not available in any of the culture collections.
Each strain was cultured independently three times, each culture-
derived extract was spotted three times, and each spot was
measured three times onMALDI-TOFMS to generate 27 spectra
in total per strain. Altogether, 864 spectra within the mass range
of 2,000–20,000 Da were acquired. The spectra quality in terms
of peak presence and intensity were assessed using Flex analysis
software. The flat line spectra and low-intensity spectra were
replaced by newmeasurement of the same spots or fresh spotting
of the same protein extract.
As shown in Figure 1, different genotypes displayed distinct
peak patterns and the spectral sets of each strain were fully
reproducible and comparable.
The spectra of the same strains showed a high level of
similarity, with the CCI value ranging from 0.78 to 0.94
(Figure 2). Genotype I displayed CCI within the range of 0.78
to 0.99 while it was between 0.82 and 0.91 for genotype II, 0.80
to 0.94 for genotype III, 0.83 for a single genotype IV strain,
0.83 to 0.94 for genotype V, and 0.88 to 0.91 for genotype VI.
The resulted CCI values reflected the similarities of the measured
spectra sets. The CCIs between different genotypes displayed
lower values indicating the possibility for spectra fingerprinting
of genotype level discrimination.
The created M. kansasii genotype MSPs were then matched
to the augmented BDAL database described earlier to generate
the cross-matching result. Then, the first hits log score values
were imported in MS excel and a heat map was generated
using MS excel conditional color formatting option following
the manufacturer’s cut-off values (Supplementary Figure 1). The
MSPs of any given strain matched 100% with themselves, as
indicated by the log score of 3.0, and had high matching scores
with the other strains within a genotype. The seven strains
without any genotype information included in the original
version of the manufacturer’s database, displayed higher score
values among each other, although theMSPs had been configured
upon a much lower number of spectra. The manufacturer’s
MSPs displayed log score values of >2.0 with several strains of
newly added genotype I and borderline or genus-level matching
was observed with genotype III, IV, and V strains. One of the
manufacturer’s MSP (S.No. 37) did not match any of the newly
introduced genotype-specific MSPs.
In addition, the individual spectra used for MSP creation were
matched first with the manufacturer’s database (BDAL database-
plus in-house entries of Staphylococcus intermedius group and
microalgae Prototheca species) and then after introduction of our
genotype-specific MSPs. This enhanced considerably the overall
identification confidence and identification at the genotype level
with first hits always being the same strain (Figure 3).
Frontiers in Microbiology | www.frontiersin.org 4 April 2018 | Volume 9 | Article 587
Murugaiyan et al. MALDI Spectra Database of Mycobacterium kansasii
FIGURE 1 | Representative raw spectra of M. kansasii genotypes (A) overlaid view of spectra sets (n = 27) of genotype I (strain 1010001495), genotype II (Strain
2193/11), genotype III (strain1010001468), genotype IV (strain 1010001458), genotype V (strain 6097/16), and genotype VI (strain NLA 001001166). (B) Heat map
view of spectra acquired from a single strain (genotype I strain 1010001495). (C) Stacked view indicating the uniformity among spectra acquired from a genotype I
strain 1010001495 and highlighted overlaid view as an inserted figure.
FIGURE 2 | Composite Correlation Index (CCI) matrix as calculated using Biotyper RTC software with the following parameter settings: 3,000 lower bound, 15,000
upper bound, mass range resolution of 4 and number of interval set at 4. The CCI values were extracted and the displayed image was redrawn using conditional
formatting option in MS Excel. The CC value nearing 1.0 indicates the congruence among the measured spectra sets and 0 represents completely different spectra.
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FIGURE 3 | Box plot of log score values before and after creation of in-house database for M. kansasii genotypes. Plots show mean and median (horizontal lines
within each boxes), 5th and 95th percentiles (whiskers) and outliers (black dots) for each set of the measured spectra. Log score values compared to the database
before (white boxes) and after (gray) creation of genotype-specific reference spectra indicate improvement in the identification confidence.
As shown in Figure 4, a score-oriented dendrogram
demonstrated two major clusters. The first cluster contained
all genotype I strains and two genotype VI strains. The second
cluster accommodated all type II, III, IV, and V strains.
The augmented genotype-specific reference database was
tested with 104 blind-coded samples, representing clinical
isolates of M. kansasii (n = 100) and single strains of
M. conspicuum, M. gastri, M. marimum, and M. szulgai, to find
any cross-matching withM. kansasii database. The identification
rates were significantly higher for the expandedMALDI Biotyper
database when compared with the original library (Table 2). In
Figure 5, a shift of identification confidence is shown for all
100 blind-coded M. kansasii samples (Supplementary Table 1).
The augmented database resulted in an overall identification
success rate of 97% isolates identified at the species/genotype
level, among which 7 isolates, representatives of genotype I, were
identified at the genus level. Two genotype I isolates could not be
identified despite the first hit as the correct genotype but with log
score value <1.7. One isolate (M. kansasii 17.14) did not display
any improvement in the log score value despite the database
augmentation. The results also indicated that, 89 strains belonged
to genotype I (19-SI, 63-PSI, and 7-PGI), 4 – to genotype II,
and 2 – to genotype III. Single isolates were recognized as
representing genotypes IV and V. Whereas the MALDI Biotyper
using the manufacture’s BDAL database displayed “Not reliable
identification” for 15% isolates of genotype I and six other
genotype isolates. Two genotype II isolates were identified only
asMycobacterium sp.
DISCUSSION
MALDI-TOF MS profiling has been successfully employed in
various commercial software packages allowing the identification
of a wide array of Mycobacterium species, including M. kansasii.
The discrimination of different M. kansasii genotypes is useful
for the clinical categorization of M. kansasii infection, however,
it has never been attempted by MALDI-TOF analysis (Pignone
et al., 2006; El Khechine et al., 2011; Saleeb et al., 2011; Balada-
Llasat et al., 2013; Chen et al., 2013; Machen et al., 2013;
Mather et al., 2014; Mediavilla-Gradolph et al., 2015; Rodriguez-
Sanchez et al., 2015; Wilen et al., 2015; Ceyssens et al., 2017;
Leyer et al., 2017). M. kansasii genotype level information
is still not included in the commercial reference database
package, MBT Mycobacteria library. Previously, identification
of M. kansasii with low spectral scores was linked to the intra-
species heterogeneity, and supplementation of the database with
additional strains of M. kansasii was proposed to remedy this
problem (El Khechine et al., 2011; Saleeb et al., 2011). Responding
to this necessity, this study established MSPs for all M. kansasii
genotypes (I–VI), except for the genotype VII (Taillard et al.,
2003), for which strains could not be retrieved in any of the
culture collection, which could not be retrieved from any culture
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FIGURE 4 | Score-oriented dendrogram of genotype-specific MSPs (distance measure was set at correlation and linkage was set at complete).
collections. It has to be noted, however, that given the paucity
of genotype II-VI strains, differentiation of these types may still
pose certain difficulties, and much more strains would be needed
to verify the genotype-specificity of the MALDI-TOF profiles
established.
Inspection with Flex analysis software, the spectral profiles
of the M. kansasii genotypes clearly showed their disparateness.
At the same time, a high intra-genotype reproducibility of the
spectra was demonstrated. The spectra sets acquired from the
same strains and from strains representing the same genotypes
were highly consistent, as evidenced with the computed CCI
values.
The cross identification of the established MSPs together
with seven MSPs originally deposited in the manufacturer’s
database resulted in a log score value of 3.0 indicating
matching of the 70 most frequently encountered peaks
of the species or genotypes. When compared against the
manufacturer’s database, with exception of genotypes I and
II, whose spectra matched those of M. kansasii, all other
genotypes produced spectra ascribable to merelyMycobacterium
genus level. It clearly proved that the existing database is not
sufficient for genotype-level discrimination of M. kansasii.
Special mycobacteria library with lowered threshold log
score values of 1.6 and 1.8 was implemented for genus and
species identification. It was later reported that the log score
values for M. kansasii were unchanged with the improved
mycobacteria library (Rodríguez-Sánchez et al., 2016). In
the present study, augmentation of genotype-specific MSPs
resulted in an enhanced log score value, which indicates that
the identification confidence improvement can be mainly
achieved through inclusion of genotypically well-defined
strains.
The grouping, as shown on score-oriented dendrogram, of
genotypes I, II, and VI in three distinct clusters supports the
potential of MALDI-TOF to easily differentiate between these
three types. Whereas identification of genotypes III, IV, and V
may pose certain difficulties, since they all belonged to a single
cluster. Inclusion of additional strains of these genotypes may
produce better identification scores.
The blind coded M. kansasii samples tested with augmented
genotype specific MSPs resulted in an overall identification
success rate of 97%. Eighty-eight (98%) out of 91 blinded coded
samples of genotype I gave a genotype match, despite the fact
that log score values for seven strains were within the genus level
cutoff (1.7–1.99). Four strains of genotype II, two of genotype
III, and single strains of genotype IV and V were used for blind
coded study, which resulted in successful identification of all
strains at the species level, otherwise, except one genotype II
strain, all these strains resulted in log score value <1.7 before
the MSP augmentation. Despite an exhaustive search through
culture collections of M. kansasii strains, genotype II–IV strains
were seriously underrepresented. According to previous studies,
M. kansasii involved in human disease belong almost exclusively
to genotypes I and II, with the former accounting for 42–100%
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FIGURE 5 | Polar plot was constructed to show the enhancement of log score values of blind-coded M. kansasii isolates (n = 100). No difference in the log score
values were observed for the four non-M. kansasii species included in the database evaluation.
TABLE 2 | Identification results of 100 blind-coded M. kansasii and one each of M. conspicuum, M. marinum, M. szulgai, and M. gastri strains using MALDI Biotyper
Explorer Compass 4.1 reference database and after augmentation of genotype-specific reference database.
Identification result Score MALDI Biotyper explorer compass 4.1 Augmented genotype-specific database
Not reliable identification (NRI) <1.7 23 (23%) 3 (3%)
Probable genus identification’ (PGI) 1.7–2.0 40 (40%) 7 (7%)
Secure genus identification and probable species identification (PSI) 2.0–2.3 37 (37%) 69 (69%)
Highly probable species identification(SI) >2.3 0 21 (21%)
of the clinical isolations (Alcaide et al., 1997; Bakuła et al.,
2013). The other types (III-VII), only sporadically recovered,
are predominantly of environmental origin (Alcaide et al., 1997;
Santin et al., 2004). The reason why seven isolates could be
identified at the genus level only, and three isolates unidentifiable
at all can hardly be found. We propose that the addition
of spectra from genotype II-VI from various geographical
regions could enable accurate and rapid differentiation of these
genotypes.
In conclusion, unique, reproducible spectra for six genotypes
of M. kansasii were established. The expansion of the database
with reference spectra resulted in successful species- and
genotype-level identification despite the limited number of
genotype II–VI strains. Overall, we believe that MALDI-TOFMS
can easily be employed for efficient genotype-level discrimination
ofM. kansasii and that further augmentation of spectral patterns
might enable fast and accurate diagnosis in future.
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2018.00587/full#supplementary-material
Supplementary Figure 1 | MSP matching matrix was created by matching with
M. kansasii genotype-specific MSPs augmented BDAL database. Color coded as
per the manufacturer’s recommendation on log score cutoff values.
Supplementary Table 1 | Blind coded isolates testing. Manufacturers
recommended interpretation of score values were followed: from 0 to 1.699
indicates “no reliable identification” (Red); 1.7 to 1.999 indicate a “probable genus
identification” (yellow); 2.0 to 2.299 indicate a “secure genus identification and
probable species identification” (light green), and values from 2.300 to 3.000
indicate a “highly probable species identification” (intensive green).
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